The present invention relates to the method of treatment for immune-mediated neurodegenerative diseases using alimentary administration, for example oral administration, of immunoglobulin. More particular, autistic spectrum disorder is treated using oral administration of immunoglobulin.
Use of oral gammaglobulin for the treatment of immune-mediated diseases